Advertisement

Inpharma Weekly

, Volume 1489, Issue 1, pp 19–19 | Cite as

Losartan, not spironolactone, reduces LVM and sympathetic activity

Clinical study
  • 4 Downloads

Keywords

Hypertension Obesity Losartan Randomise Study Obese Subject 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2005

Personalised recommendations